NAD+ 1G & RETATRUTIDE : A BRITISH UPDATE

The growing interest in NAD+ supplementation, particularly at a high dosage of one gram, continues to rise within the British medical community. At the same time , attention is directed toward Retatrutide, a groundbreaking GLP-1 receptor agonist being viewed by many as a potential advancement to